Further to the letter dated February 26, 2018, UPL has now informed that the wholly-owned subsidiary, UPL Corporation (formerly Biowin Corporation Limited) has successfully completed the pricing of its $ 300 million senior unsecured notes (Notes) at 4.5 % per annum, due 2028. The Notes have been rated BBB- by Fitch, and BBB- by S&P. An application is filed to the Singapore Stock Exchange for the listing of the Notes. The offering is scheduled to close on March 8, 2018.
The above information is a part of company’s filings submitted to BSE.
